Trexquant Investment’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Trexquant Investment’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,576	Closed	-$135K	–	1657
2020 Q3	$135K	Sell	11,576 -32,440	-74%	-$431K	0.01%	1128
2020 Q2	$572K	Buy	+44,016	New	+$529K	0.04%	625
2019 Q2	–	Sell	-20,202	Closed	-$348K	–	1267
2019 Q1	$348K	Buy	+20,202	New	+$320K	0.02%	700
2018 Q4	–	Sell	-17,195	Closed	-$279K	–	1416
2018 Q3	$279K	Buy	+17,195	New	+$246K	0.02%	706
2018 Q2	–	Sell	-38,064	Closed	-$474K	–	1361
2018 Q1	$474K	Buy	38,064 +23,353	+159%	+$284K	0.03%	657
2017 Q4	$206K	Buy	+14,711	New	+$216K	0.02%	931

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trexquant Investment's OXFD Position: Q4 2020 in Review

Trexquant Investment sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 11,576 shares — an estimated $135K sold.

Trexquant Investment first reported a position in OXFD in Q4 2017 and held it in 6 quarters. The position peaked at $572K in Q2 2020. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

Trexquant Investment reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Trexquant Investment sold 11,576 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $135K.
Trexquant Investment first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2017 and held it in 6 quarters.
Trexquant Investment's Oxford Immunotec Global PLC Ordinary Shares position peaked at $572K in Q2 2020.
60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Trexquant Investment's 13F filing for Q4 2020, filed 11 Feb 2021.